The collaboration brings together Caris' extensive genomic data and molecular expertise with Ontada's robust clinical data and research capabilities to drive next-gen therapeutic development and advance cancer care
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced a strategic and multi-faceted collaboration with Ontada®, a...
Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapy
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced a proposed collaboration with Guardant Health, Inc., a leading precision oncology company, to address challenges in lung cancer care. The collaboration aims to...
Atropos Health’s platform, including GENEVA OS™ and the Atropos Evidence™ Network Launches AI Model for Precision Medicine at Scale
Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, announced the deployment of AI models for patient identification of patients living with undiagnosed conditions. The AI models...
IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence, announced a strategic collaboration with NVIDIA to help realize the potential of AI in healthcare and life sciences.
The healthcare and life sciences industries generate vast amounts of data, representing significant potential for AI-powered solutions. This...
Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, announced the initiation of an indication expansion study of TOS-358, the first covalent PI3Kα inhibitor in clinical development and the appointment of Zelanna Goldberg, M.D., M.A.S., as Chief Medical Officer.
“Following the...
Ovation.io, a leading provider of research-focused data solutions, announced the launch of a groundbreaking research data set that combines whole genome sequencing (WGS) data with longitudinal clinical records of patients treated with GLP-1 receptor agonists. This initiative will culminate with the inclusion of 8,500 patient records by the end...
OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which has the world’s largest immunology clinico-transcriptomics data set and is focused on advancing precision medicine with proprietary AI network biology solutions, announced a partnership to advance precision medicine efforts for immunology.
This collaboration...
Prudentia Sciences, an AI-powered technology platform for life sciences announced its public launch, supported by $7 million in funding. The funding round was led by GV, with participation from Iaso Ventures and Virtue. The company aims to empower biopharma companies to accelerate drug pipelines and maximize return on investment, ensuring healthcare innovations...
Tempus AI, Inc, a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA-based algorithms across cancer types.
Clinical care for cancer patients is...
This collaboration combines real world clinical EMR data from a large footprint of cancer centers with research grade multi-omics data collected at key treatment timepoints. These data and linked biobanked samples support discovery of novel biomarkers that will inform treatment decision-making and improve patient outcomes.
The ONCare Alliance, representing 32...
